A major methodological advantage of the switching replication design is its built-in replication, which verifies a treatment's effectiveness across two distinct samples within a single experiment. The delayed rollout of the intervention also effectively rules out many internal validity threats, such as history effects, because it is highly unlikely that an extraneous event would happen to coincide perfectly with the treatment's introduction for the first group and later for the second. Similarly, it controls for maturation and instrumentation, as naturally occurring changes like spontaneous remission or shifts in measurement tools would likely appear simultaneously in both groups. Despite these robust controls, researchers must still account for other persistent threats, including demand characteristics, placebo effects, and experimenter expectancy.